Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Withdrawn 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Other 1

Conditions

Breast Neoplasms 4Vitamin D Deficiency 2Triple Negative Breast Neoplasms 1Obesity 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Bone Metabolism Biomarkers 1

Interventions

Fulvestrant 64Paclitaxel 55Letrozole 54Trastuzumab 43pembrolizumab 41ribociclib 39Capecitabine 36palbociclib 35Specimen Handling 34Carboplatin 34Anastrozole 34exemestane 31abemaciclib 31Tamoxifen 31pertuzumab 29Cyclophosphamide 27Magnetic Resonance Spectroscopy 25trastuzumab deruxtecan 24Surveys and Questionnaires 21Radiotherapy 21Blood Specimen Collection 21olaparib 18Standard of Care 17Docetaxel 17Biopsy 17130-nm albumin-bound paclitaxel 16eribulin 14Taxes 14Methods 14Mastectomy, Segmental 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Breast Neoplasms × Cholecalciferol × 90 days × Clear all
NCT01472445 2026-04-23

Vitamin D and Breast Cancer: Does Weight Make a Difference?

Stanford University

Phase 2 Terminated
41 enrolled 16 charts
BreastOther

Breast Neoplasms, Obesity

NCT02856503 2026-04-17

Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors

University of Miami

Phase 1/2 Withdrawn
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04067726 2026-03-31

TRIDENT

Washington University School of Medicine

Phase 2 Active not recruiting
210 enrolled
Breast

Breast Neoplasms

NCT01480869 2026-03-12

VITACAL

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Completed
215 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡